GLP-1 Drugs and Menopause Weight Loss: Ozempic, Wegovy and Zepbound Explained
This article contains affiliate links. As an Amazon Associate, we earn from qualifying purchases, at no extra cost to you. Learn more.
GLP-1 based medicines such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) can work well for midlife women with obesity or overweight and related health problems, including after menopause. In large trials, people lost an average of about 15 to 20 percent of body weight. A growing set of Mayo Clinic studies also suggests women on menopause hormone therapy may lose a bit more on these drugs. The catch for women over 45: fast weight loss can take muscle and bone with it, so strength training and plenty of protein are essential, and these are prescription medicines with real side effects.
| Medicine | Brand names | Average weight loss in key trials |
|---|---|---|
| Semaglutide 2.4 mg weekly | Wegovy (Ozempic is the diabetes version) | About 15 percent at 68 weeks (STEP 1) |
| Tirzepatide up to 15 mg weekly | Zepbound (Mounjaro is the diabetes version) | About 15 to 21 percent at 72 weeks, depending on dose (SURMOUNT-1) |
How do GLP-1 medicines work?
They mimic gut hormones that your body releases after eating. They slow how fast your stomach empties, help your pancreas release insulin when blood sugar rises, and act on the brain to reduce hunger and food noise. Tirzepatide also acts on a second hormone pathway, GIP. Most people simply feel full sooner and think about food less.
They are usually prescribed for adults with a body mass index of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, prediabetes or sleep apnea. Semaglutide has also been shown to reduce the risk of heart attack and stroke in people with heart disease and overweight.
Do GLP-1 drugs work as well after menopause?
Yes. Postmenopausal women in trials lost substantial weight. The interesting newer question is whether menopause hormone therapy changes the response:
- 2024, semaglutide: a Mayo Clinic study in the journal Menopause found postmenopausal women using hormone therapy lost more weight on semaglutide than women not using it, after adjusting for other factors.
- 2025, tirzepatide: in a smaller Mayo Clinic study of 120 women presented at the Endocrine Society meeting, hormone therapy users lost about 17 percent of body weight versus about 14 percent for nonusers.
- 2026, larger study: in about 3,900 women presented at The Menopause Society meeting, one-year weight loss on semaglutide was about 11 percent with hormone therapy versus 9.5 percent without. The difference with tirzepatide was smaller.
These are observational studies, so they cannot prove cause and effect. The researchers themselves stress that weight loss is not a reason to start hormone therapy. But for women who already need hormone therapy for hot flashes or other symptoms, the findings are reassuring.

What are the risks for women over 45?
Muscle and bone loss
When weight drops quickly, part of what is lost is lean tissue, including muscle. Studies of these drugs have found that roughly a quarter to a third or more of the weight lost can be lean mass. For women already losing muscle and bone after menopause, that matters. See how fast you lose bone in menopause.
To protect yourself:
- Strength train 2 to 3 times a week. Start with our beginner strength plan.
- Eat enough protein, often 1.2 grams per kilogram of body weight or more during weight loss. Smaller appetites make this harder, so plan it. See protein powder for women in menopause.
- Get enough calcium and vitamin D, and ask about a bone density scan if you are at risk.
Common side effects
Nausea, vomiting, diarrhea, constipation and reflux are common, especially when the dose goes up. Most improve over time. Eating smaller meals, stopping when full and avoiding very fatty foods help.
Less common but serious
- Gallbladder problems and pancreatitis
- Dehydration and kidney strain from vomiting or diarrhea
- A boxed warning about a type of thyroid tumor seen in rodents. These drugs are not used in people with a personal or family history of medullary thyroid cancer or MEN2.
Compounded and online versions
Be cautious with compounded semaglutide or tirzepatide sold online. The FDA has received reports of dosing errors and products that may contain the wrong ingredient. Use a licensed prescriber and a legitimate pharmacy.
What happens if you stop?
Most people regain much of the weight within a year of stopping, because appetite returns. That is why doctors treat these as long-term medicines, much like blood pressure pills. Muscle you build with strength training while on the drug helps you keep more of the benefit.
What could a well-planned start look like?
Here is one example. A 54-year-old woman with prediabetes and a BMI of 33 starts semaglutide. Before her first dose, she books a bone density scan, joins a twice-weekly strength class and plans a protein-rich breakfast every day. Her doctor raises the dose slowly. A year later she has lost about 14 percent of her body weight, her A1C is in the normal range, and her strength numbers have gone up rather than down.
Are GLP-1 drugs right for you?
Questions to bring to your doctor:
- Do I meet the criteria, and will my insurance cover it?
- How will we protect my muscle and bone?
- Do my hot flashes or other symptoms mean hormone therapy is worth considering too?
- What side effects should make me call you?
- What is the long-term plan if I stop?
For the bigger picture on midlife weight, see why menopause causes belly fat and insulin resistance and menopause.
What does a menopause doctor say about GLP-1 medicines?
Jennifer Roelands, MD, explains how GLP-1 medications fit into weight management during perimenopause and menopause, in about four minutes.
What helps protect muscle while losing weight?
These support the most important habits while on a GLP-1 medicine: strength work, enough protein and tracking progress. Our picks:
- Adjustable Dumbbell Set: One set covers a full home strength routine to protect muscle as the scale drops. Check price on Amazon
- NSF Certified Whey Protein Isolate: An easy way to hit protein goals when appetite is low. Check price on Amazon
- Body Composition Smart Scale: Rough estimates of muscle and fat trends over time, so you notice if muscle drops. Not as accurate as a DXA scan. Check price on Amazon
- The New Menopause by Mary Claire Haver, MD: Background on midlife weight, hormones and treatment options before your appointment. Check price on Amazon
Frequently asked questions
Does Ozempic work for menopause belly fat?
GLP-1 medicines reduce overall body fat, including belly fat, in people who qualify for them. They are not approved specifically for menopause weight gain, and lifestyle steps remain the foundation.
Should I start hormone therapy to lose more weight on Wegovy or Zepbound?
No. Researchers stress that weight loss is not a reason to start hormone therapy. If you have menopause symptoms and are a good candidate, discuss both with your doctor.
Will I lose muscle on a GLP-1 drug?
Some lean mass loss is common with any fast weight loss. Strength training and enough protein reduce it.
How long do I need to stay on it?
Many people regain weight after stopping, so doctors often plan for long-term use. Discuss your goals and options before you start.
Sources and further reading
- Weight loss response to semaglutide in postmenopausal women with and without hormone therapy, Menopause (PubMed Central)
- Hormone therapy and tirzepatide weight loss in postmenopausal women, Endocrine Society via ScienceDaily
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), New England Journal of Medicine
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss, U.S. Food and Drug Administration
A quick note: this is general health information, not medical advice. Talk with your doctor before starting, stopping, or changing any treatment.